NEW YORK, April 15 /PRNewswire-FirstCall/ -- CryoPort, Inc. (OTC
Bulletin Board: CYRX) (http://www.CryoPort.com) will be updating the investment
community through their personal profile on MyWallst.net available at
http://www.wallst.net. The dynamic profile will include interviews with company
representatives, on which investors can comment, and links to recent press.
Visit CryoPort's profile on Mywallst.net at http://my.wallst.net/profile.php?ID=19849.
Stay updated about CryoPort, Inc., post a comment on their personal page, join CryoPort's message board to discuss company activity with other interested parties, "invest" in OTCBB: CYRX through the Rookie Challenge and join his financial social network today.
http://www.wallst.net is owned and operated by WallStreet Direct, Inc., a wholly owned subsidiary of Financial Media Group, Inc. (http://www.financialmediagroupinc.com). The Web site is a leading provider of timely business news, executive interviews, multimedia content, and research tools. Financial Media Group, Inc. also owns http://my.wallst.net, a financial social network for investors, and Financial Filings Corp. (http://www.financialfilings.com), a provider of compliance solutions to publicly traded companies. We have received nine hundred ninety five dollars from CryoPort, Inc. for media and advertising services. In addition to WallSt.net, WallStreet Direct, Inc. owns and operates WallStRadio (http://www.wallstradio.com), a business and finance podcast Web site.
About CryoPort, Inc.:
CryoPort develops leading edge, proprietary, technology-driven shipping
and storage products for use in the rapidly growing global biotechnology
and biopharmaceutical cold chain. The products developed by CryoPort are
essential components of the infrastructure required for the testing,
research and end user delivery of temperature-sensitive medicines and
biomaterials in an increasingly complex logistical environment. The Company
offers a complete end to end shipping solution with its products for
pharmaceutical clinical trials, gene biotechnology, transport of infectious
materials and dangerous goods and pharmaceutical distribution. It markets
its services directly in the Americas, Europe, and Asia. The company was
founded in 1999.
Contact: CryoPort, Inc.
|SOURCE CryoPort, Inc.|
Copyright©2008 PR Newswire.
All rights reserved